S Michael Crawford

Summary

Affiliation: Airedale General Hospital
Country: UK

Publications

  1. pmc Social and geographical factors affecting access to treatment of lung cancer
    S M Crawford
    Airedale General Hospital, Skipton Road, Steeton, Keighley, West Yorkshire BD20 6TD, UK
    Br J Cancer 101:897-901. 2009
  2. ncbi request reprint Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
    S M Crawford
    Department of Medical Oncology, Airedale General Hospital, Skipton Road, Steeton, Keighley BD20 6TD, UK
    Ann Oncol 16:47-50. 2005
  3. ncbi request reprint A visitor with Munchausen's syndrome
    S Michael Crawford
    Airedale General Hospital, Keighley, West Yorkshire
    Clin Med 5:400-1. 2005
  4. ncbi request reprint Centralisation of services for the management of ovarian cancer: arguments against
    S M Crawford
    Department of Medical Oncology and Gynaecology, Airedale General Hospital, West Yorkshire, UK
    BJOG 114:1183-5; discussion 1186-7. 2007
  5. ncbi request reprint Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma
    L C Barker
    Oncology Department, Airedale General Hospital, Steeton, UK
    Curr Med Res Opin 25:1105-9. 2009
  6. doi request reprint A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract
    M S Highley
    Department of Medical Oncology, Guy s Hospital, St Thomas Street, London SE1 9RT, UK
    Clin Oncol (R Coll Radiol) 21:394-400. 2009
  7. pmc The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy
    S M Crawford
    Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London, UK
    Br J Cancer 59:243-6. 1989
  8. ncbi request reprint Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
    Christopher J Poole
    Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom
    N Engl J Med 355:1851-62. 2006
  9. doi request reprint Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin
    Ivo M Hennig
    Cancer Research UK Centre, St James s Institute of Oncology, St James s University Hospital, Leeds LS9 7TF, United Kingdom
    J Clin Oncol 26:3411-7. 2008
  10. pmc Waiting for radiotherapy: financing increased capacity is a must
    S Michael Crawford
    BMJ 332:235. 2006

Collaborators

Detail Information

Publications12

  1. pmc Social and geographical factors affecting access to treatment of lung cancer
    S M Crawford
    Airedale General Hospital, Skipton Road, Steeton, Keighley, West Yorkshire BD20 6TD, UK
    Br J Cancer 101:897-901. 2009
    ..Cancer survival is inferior to that of other Western European countries. We have used cancer registry data to assess factors associated with access to diagnosis and treatment of lung cancer in northern England...
  2. ncbi request reprint Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary?
    S M Crawford
    Department of Medical Oncology, Airedale General Hospital, Skipton Road, Steeton, Keighley BD20 6TD, UK
    Ann Oncol 16:47-50. 2005
    ..001). Variations in the CA125 value even within the normal range carry useful information. This prognostic indicator will be useful in studying the management of patients following response to first-line chemotherapy...
  3. ncbi request reprint A visitor with Munchausen's syndrome
    S Michael Crawford
    Airedale General Hospital, Keighley, West Yorkshire
    Clin Med 5:400-1. 2005
    ..The article describes the experience of three members of staff with a patient who proved to have Munchausen's syndrome, and their reaction to discovering the truth...
  4. ncbi request reprint Centralisation of services for the management of ovarian cancer: arguments against
    S M Crawford
    Department of Medical Oncology and Gynaecology, Airedale General Hospital, West Yorkshire, UK
    BJOG 114:1183-5; discussion 1186-7. 2007
    ..We argue for investment in the diagnosis of ovarian cancer and the provision of services for its medical treatment over a prolonged period...
  5. ncbi request reprint Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma
    L C Barker
    Oncology Department, Airedale General Hospital, Steeton, UK
    Curr Med Res Opin 25:1105-9. 2009
    ....
  6. doi request reprint A phase II trial of continuous 5-fluorouracil in recurrent or metastatic transitional cell carcinoma of the urinary tract
    M S Highley
    Department of Medical Oncology, Guy s Hospital, St Thomas Street, London SE1 9RT, UK
    Clin Oncol (R Coll Radiol) 21:394-400. 2009
    ..To assess the activity of a continuous infusion of 5-fluorouracil in patients with recurrent locally advanced or metastatic transitional cell carcinoma of the urinary tract...
  7. pmc The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy
    S M Crawford
    Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross Hospital, London, UK
    Br J Cancer 59:243-6. 1989
    ..They showed no significant differences between the two groups. These results emphasise the importance of ensuring that patients with these curable cancers receive adequate doses of chemotherapy...
  8. ncbi request reprint Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer
    Christopher J Poole
    Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Birmingham, United Kingdom
    N Engl J Med 355:1851-62. 2006
    ..The National Epirubicin Adjuvant Trial (NEAT) and the BR9601 trial examined the efficacy of anthracyclines in the adjuvant treatment of early breast cancer...
  9. doi request reprint Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin
    Ivo M Hennig
    Cancer Research UK Centre, St James s Institute of Oncology, St James s University Hospital, Leeds LS9 7TF, United Kingdom
    J Clin Oncol 26:3411-7. 2008
    ..These treatments have similar efficacy but differ in convenience and toxicity. We therefore wished to compare their overall acceptability to patients...
  10. pmc Waiting for radiotherapy: financing increased capacity is a must
    S Michael Crawford
    BMJ 332:235. 2006
  11. ncbi request reprint Recruitment of patients to clinical trials: an ambitious undertaking for the UK
    S Michael Crawford
    Clin Oncol (R Coll Radiol) 14:335-6. 2002
  12. pmc Two week rule: Breast cancer experience has wider implications
    S Michael Crawford
    BMJ 335:361. 2007